Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1046 entries
Sorted by: Best Match Show Resources per page
Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes.

Clinical ophthalmology (Auckland, N.Z.)

Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, Miller D, Hofling-Lima AL.
PMID: 24039389
Clin Ophthalmol. 2013;7:1693-701. doi: 10.2147/OPTH.S40063. Epub 2013 Aug 29.

BACKGROUND: The purpose of this paper is to describe clinical characteristics and determine correlations between clinical outcomes and antifungal susceptibility among molecularly characterized ocular Fusarium isolates in Brazil.METHODS: Forty-one Fusarium isolates obtained from 41 eyes of 41 patients were...

Cite
Oechsler RA, Yamanaka TM, Bispo PJ, et al. Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol. 2013;7:1693-701doi: 10.2147/OPTH.S40063.
Oechsler, R. A., Yamanaka, T. M., Bispo, P. J., Sartori, J., Yu, M. C., Melo, A. S., Miller, D., & Hofling-Lima, A. L. (2013). Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clinical ophthalmology (Auckland, N.Z.), 71693-701. https://doi.org/10.2147/OPTH.S40063
Oechsler, Rafael A, et al. "Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes." Clinical ophthalmology (Auckland, N.Z.) vol. 7 (2013): 1693-701. doi: https://doi.org/10.2147/OPTH.S40063
Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, Miller D, Hofling-Lima AL. Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol. 2013;7:1693-701. doi: 10.2147/OPTH.S40063. Epub 2013 Aug 29. PMID: 24039389; PMCID: PMC3769409.
Copy Download .nbib Format: NLM
Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi.

Case reports in ophthalmology

Chaidaroon W, Tananuvat N, Chavengsaksongkram P, Vanittanakom N.
PMID: 25873892
Case Rep Ophthalmol. 2015 Feb 27;6(1):82-7. doi: 10.1159/000380759. eCollection 2015.

PURPOSE: To report 2 unusual cases of fungal keratitis due to Fonsecaea pedrosoi.METHODS: Two patients were diagnosed with Fonsecaea pedrosoi keratitis. Their files were reviewed for predisposing factors, clinical characteristics, microbiological study, treatment, and outcome.RESULTS: Two consecutive patients presented...

Cite
Chaidaroon W, Tananuvat N, Chavengsaksongkram P, et al. Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi. Case Rep Ophthalmol. 2015;6(1):82-7doi: 10.1159/000380759.
Chaidaroon, W., Tananuvat, N., Chavengsaksongkram, P., & Vanittanakom, N. (2015). Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi. Case reports in ophthalmology, 6(1), 82-7. https://doi.org/10.1159/000380759
Chaidaroon, Winai, et al. "Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi." Case reports in ophthalmology vol. 6,1 (2015): 82-7. doi: https://doi.org/10.1159/000380759
Chaidaroon W, Tananuvat N, Chavengsaksongkram P, Vanittanakom N. Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi. Case Rep Ophthalmol. 2015 Feb 27;6(1):82-7. doi: 10.1159/000380759. eCollection 2015. PMID: 25873892; PMCID: PMC4376933.
Copy Download .nbib Format: NLM
Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis.

Advanced biomedical research

Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F.
PMID: 26015921
Adv Biomed Res. 2015 May 11;4:95. doi: 10.4103/2277-9175.156659. eCollection 2015.

BACKGROUND: Onychomycosis is one of the most common clinical forms of fungal infections due to both filamentous fungi and yeasts. The genus of Candida is one of the most prominent causes of onychomycosis in all around the world. Although...

Cite
Mohammadi R, Badiee P, Badali H, et al. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015;4:95doi: 10.4103/2277-9175.156659.
Mohammadi, R., Badiee, P., Badali, H., Abastabar, M., Safa, A. H., Hadipour, M., Yazdani, H., & Heshmat, F. (2015). Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Advanced biomedical research, 495. https://doi.org/10.4103/2277-9175.156659
Mohammadi, Rasoul, et al. "Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis." Advanced biomedical research vol. 4 (2015): 95. doi: https://doi.org/10.4103/2277-9175.156659
Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015 May 11;4:95. doi: 10.4103/2277-9175.156659. eCollection 2015. PMID: 26015921; PMCID: PMC4434489.
Copy Download .nbib Format: NLM
Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

McDonald EM, Ram FS, Patel DV, McGhee CN.
PMID: 26107307
Asia Pac J Ophthalmol (Phila). 2014 Jan-Feb;3(1):41-7. doi: 10.1097/APO.0b013e3182a618dd.

Fungal keratitis (FK) typically requires intensive therapy with topical antifungal agents. To date, evidence from clinical trials has been conflicting with respect to the most effective topical antifungal drug in the treatment of FK. Therefore, a systematic review and...

Cite
McDonald EM, Ram FS, Patel DV, et al. Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Asia Pac J Ophthalmol (Phila). 2014;3(1):41-7doi: 10.1097/APO.0b013e3182a618dd.
McDonald, E. M., Ram, F. S., Patel, D. V., & McGhee, C. N. (2014). Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 3(1), 41-7. https://doi.org/10.1097/APO.0b013e3182a618dd
McDonald, Elissa M, et al. "Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) vol. 3,1 (2014): 41-7. doi: https://doi.org/10.1097/APO.0b013e3182a618dd
McDonald EM, Ram FS, Patel DV, McGhee CN. Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Asia Pac J Ophthalmol (Phila). 2014 Jan-Feb;3(1):41-7. doi: 10.1097/APO.0b013e3182a618dd. PMID: 26107307.
Copy Download .nbib Format: NLM
A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation.

Journal of clinical and diagnostic research : JCDR

Srinivasnakshatri VK, Subramani P, Venkateshwaraprasad KN, Varma P.
PMID: 25584222
J Clin Diagn Res. 2014 Nov;8(11):DD01-2. doi: 10.7860/JCDR/2014/10466.5205. Epub 2014 Nov 20.

Infections of the pleural cavity remain an important cause of morbidity and mortality despite advancement in diagnostic modalities and therapy. Community acquired empyema thoracis due to Candida species are rarely reported in paediatric literature. We hereby report an interesting...

Cite
Srinivasnakshatri VK, Subramani P, Venkateshwaraprasad KN, et al. A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation. J Clin Diagn Res. 2014;8(11):DD01-2doi: 10.7860/JCDR/2014/10466.5205.
Srinivasnakshatri, V. K., Subramani, P., Venkateshwaraprasad, K. N., & Varma, P. (2014). A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation. Journal of clinical and diagnostic research : JCDR, 8(11), DD01-2. https://doi.org/10.7860/JCDR/2014/10466.5205
Srinivasnakshatri, Venkatesh Karkada, et al. "A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation." Journal of clinical and diagnostic research : JCDR vol. 8,11 (2014): DD01-2. doi: https://doi.org/10.7860/JCDR/2014/10466.5205
Srinivasnakshatri VK, Subramani P, Venkateshwaraprasad KN, Varma P. A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation. J Clin Diagn Res. 2014 Nov;8(11):DD01-2. doi: 10.7860/JCDR/2014/10466.5205. Epub 2014 Nov 20. PMID: 25584222; PMCID: PMC4290240.
Copy Download .nbib Format: NLM
An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh.

Journal of oral and maxillofacial pathology : JOMFP

Dar MS, Sreedar G, Shukla A, Gupta P, Rehan AD, George J.
PMID: 26604498
J Oral Maxillofac Pathol. 2015 May-Aug;19(2):205-11. doi: 10.4103/0973-029X.164534.

BACKGROUND: Candidiasis is the most common opportunistic infection in human immunodeficiency virus (HIV) seropositive patients, starting from asymptomatic colonization to pathogenic forms and gradual colonization of non-albicans in patients with advanced immunosuppression leads to resistance for azole group of...

Cite
Dar MS, Sreedar G, Shukla A, et al. An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh. J Oral Maxillofac Pathol. 2015;19(2):205-11doi: 10.4103/0973-029X.164534.
Dar, M. S., Sreedar, G., Shukla, A., Gupta, P., Rehan, A. D., & George, J. (2015). An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh. Journal of oral and maxillofacial pathology : JOMFP, 19(2), 205-11. https://doi.org/10.4103/0973-029X.164534
Dar, Mohammad Shafi, et al. "An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh." Journal of oral and maxillofacial pathology : JOMFP vol. 19,2 (2015): 205-11. doi: https://doi.org/10.4103/0973-029X.164534
Dar MS, Sreedar G, Shukla A, Gupta P, Rehan AD, George J. An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh. J Oral Maxillofac Pathol. 2015 May-Aug;19(2):205-11. doi: 10.4103/0973-029X.164534. PMID: 26604498; PMCID: PMC4611930.
Copy Download .nbib Format: NLM
Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis.

International journal of ophthalmology

Qiu S, Zhao GQ, Lin J, Wang X, Hu LT, Du ZD, Wang Q, Zhu CC.
PMID: 26086015
Int J Ophthalmol. 2015 Jun 18;8(3):597-602. doi: 10.3980/j.issn.2222-3959.2015.03.29. eCollection 2015.

AIM: To review published clinical studies examining the effect of natamycin in the treatment of fungal keratitis.METHODS: We selected the publications in CENTRAL, MEDLINE, EMBASE, CNKI, and CBM. This study systematically reviewed published randomized controlled trials (RCTs) that compared...

Cite
Qiu S, Zhao GQ, Lin J, et al. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. Int J Ophthalmol. 2015;8(3):597-602doi: 10.3980/j.issn.2222-3959.2015.03.29.
Qiu, S., Zhao, G. Q., Lin, J., Wang, X., Hu, L. T., Du, Z. D., Wang, Q., & Zhu, C. C. (2015). Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. International journal of ophthalmology, 8(3), 597-602. https://doi.org/10.3980/j.issn.2222-3959.2015.03.29
Qiu, Sheng, et al. "Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis." International journal of ophthalmology vol. 8,3 (2015): 597-602. doi: https://doi.org/10.3980/j.issn.2222-3959.2015.03.29
Qiu S, Zhao GQ, Lin J, Wang X, Hu LT, Du ZD, Wang Q, Zhu CC. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. Int J Ophthalmol. 2015 Jun 18;8(3):597-602. doi: 10.3980/j.issn.2222-3959.2015.03.29. eCollection 2015. PMID: 26086015; PMCID: PMC4458670.
Copy Download .nbib Format: NLM
Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Shalhoub S, Wang L, Ching A, Husain S, Rotstein C.
PMID: 25587291
Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):299-304. doi: 10.1155/2014/983724.

BACKGROUND: Invasive fungal infections are associated with morbidity and mortality in neutropenia secondary to hematological malignancies. Empirical antifungal agents are used to reduce their consequences. Caspofungin is the only echinocandin approved for this indication. Micafungin was compared with caspofungin...

Cite
Shalhoub S, Wang L, Ching A, et al. Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study. Can J Infect Dis Med Microbiol. 2014;25(6):299-304doi: 10.1155/2014/983724.
Shalhoub, S., Wang, L., Ching, A., Husain, S., & Rotstein, C. (2014). Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 25(6), 299-304. https://doi.org/10.1155/2014/983724
Shalhoub, Sarah, et al. "Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 25,6 (2014): 299-304. doi: https://doi.org/10.1155/2014/983724
Shalhoub S, Wang L, Ching A, Husain S, Rotstein C. Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study. Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):299-304. doi: 10.1155/2014/983724. PMID: 25587291; PMCID: PMC4277157.
Copy Download .nbib Format: NLM
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole.

EXCLI journal

Hashemian F, Hashemian F, Molaali N, Rouini M, Roohi E, Torabian S.
PMID: 27065776
EXCLI J. 2016 Feb 05;15:95-102. doi: 10.17179/excli2015-678. eCollection 2016.

Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study...

Cite
Hashemian F, Hashemian F, Molaali N, et al. Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole. EXCLI J. 2016;15:95-102doi: 10.17179/excli2015-678.
Hashemian, F., Hashemian, F., Molaali, N., Rouini, M., Roohi, E., & Torabian, S. (2016). Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole. EXCLI journal, 1595-102. https://doi.org/10.17179/excli2015-678
Hashemian, Farshad, et al. "Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole." EXCLI journal vol. 15 (2016): 95-102. doi: https://doi.org/10.17179/excli2015-678
Hashemian F, Hashemian F, Molaali N, Rouini M, Roohi E, Torabian S. Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole. EXCLI J. 2016 Feb 05;15:95-102. doi: 10.17179/excli2015-678. eCollection 2016. PMID: 27065776; PMCID: PMC4822190.
Copy Download .nbib Format: NLM
Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis.

International journal of microbiology

Moges B, Bitew A, Shewaamare A.
PMID: 26880925
Int J Microbiol. 2016;2016:3037817. doi: 10.1155/2016/3037817. Epub 2016 Jan 05.

Background. In Ethiopia, little is known regarding the distribution and the in vitro antifungal susceptibility profile of yeasts. Objective. This study was undertaken to determine the spectrum and the in vitro antifungal susceptibility pattern of yeasts isolated from HIV...

Cite
Moges B, Bitew A, Shewaamare A. Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis. Int J Microbiol. 2016;2016:3037817doi: 10.1155/2016/3037817.
Moges, B., Bitew, A., & Shewaamare, A. (2016). Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis. International journal of microbiology, 20163037817. https://doi.org/10.1155/2016/3037817
Moges, Birhan, et al. "Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis." International journal of microbiology vol. 2016 (2016): 3037817. doi: https://doi.org/10.1155/2016/3037817
Moges B, Bitew A, Shewaamare A. Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis. Int J Microbiol. 2016;2016:3037817. doi: 10.1155/2016/3037817. Epub 2016 Jan 05. PMID: 26880925; PMCID: PMC4736391.
Copy Download .nbib Format: NLM
Athlete's Foot: Clinical Update.

The Physician and sportsmedicine

Ramsey ML.
PMID: 27448130
Phys Sportsmed. 1989 Oct;17(10):78-93. doi: 10.1080/00913847.1989.11709891.

In brief: Athletes are particularly prone to athlete's foot because they are generally more exposed than others to conditions that encourage fungal growth, eg, communal showers and locker rooms. Diagnosis of athlete's foot rests on clinical suspicion and laboratory...

Cite
Ramsey ML. Athlete's Foot: Clinical Update. Phys Sportsmed. 1989;17(10):78-93doi: 10.1080/00913847.1989.11709891.
Ramsey, M. L. (1989). Athlete's Foot: Clinical Update. The Physician and sportsmedicine, 17(10), 78-93. https://doi.org/10.1080/00913847.1989.11709891
Ramsey, M L. "Athlete's Foot: Clinical Update." The Physician and sportsmedicine vol. 17,10 (1989): 78-93. doi: https://doi.org/10.1080/00913847.1989.11709891
Ramsey ML. Athlete's Foot: Clinical Update. Phys Sportsmed. 1989 Oct;17(10):78-93. doi: 10.1080/00913847.1989.11709891. PMID: 27448130.
Copy Download .nbib Format: NLM
Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms.

Frontiers in microbiology

Watamoto T, Egusa H, Sawase T, Yatani H.
PMID: 26733987
Front Microbiol. 2015 Dec 22;6:1453. doi: 10.3389/fmicb.2015.01453. eCollection 2015.

Candida species have emerged as important and common opportunistic human pathogens, particularly in immunocompromised individuals. The current antifungal therapies either have toxic side effects or are insufficiently effect. The aim of this study is develop new small-molecule antifungal compounds...

Cite
Watamoto T, Egusa H, Sawase T, et al. Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms. Front Microbiol. 2015;6:1453doi: 10.3389/fmicb.2015.01453.
Watamoto, T., Egusa, H., Sawase, T., & Yatani, H. (2015). Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms. Frontiers in microbiology, 61453. https://doi.org/10.3389/fmicb.2015.01453
Watamoto, Takao, et al. "Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms." Frontiers in microbiology vol. 6 (2015): 1453. doi: https://doi.org/10.3389/fmicb.2015.01453
Watamoto T, Egusa H, Sawase T, Yatani H. Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms. Front Microbiol. 2015 Dec 22;6:1453. doi: 10.3389/fmicb.2015.01453. eCollection 2015. PMID: 26733987; PMCID: PMC4686731.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1046 entries